Daniel H. Hunt, M.D., FACS

Colon and Rectal Surgery
Daniel Hunt

Daniel H. Hunt, MD is a board-certified surgeon in colon and rectal surgery. Dr. Hunt is an Assistant Professor of Surgery at Weill Cornell Medical College and an Assistant Attending Surgeon at NewYork-Presbyterian/Weill Cornell Medical Center. He is the Site Chief of Colon and Rectal Surgery at New York-Presbyterian Lower Manhattan Hospital.

Dr. Hunt specializes in laparoscopy for benign and malignant colorectal tumors. His expertise also includes cancer prevention, Crohn's disease, ulcerative colitis, diverticulitis, and sphincter preservation for rectal cancer. Dr. Hunt delivers state-of-the-art care using minimally invasive techniques to speed recovery. These advanced procedures and treatment plans, combined with new technologies offer patients improved safety, comfort and the preservation of normal bowel function.

Dr. Hunt earned his M.D degree from the Mount Sinai School of Medicine in New York in 1999.  He received his B.S. in Chemistry from the State University of Albany in 1993.  Dr. Hunt began his general surgery residency at St. Barnabas Medical Center, Livingston, New Jersey from 1999 - 2001.  He spent two years as a Surgical Oncology Fellow at Weill Cornell from 2001-2003.  Dr. Hunt completed his general surgery residency at SUNY Downstate Medical Center in Brooklyn from 2003-2006.  He also completed a Minimally Invasive Colorectal Surgery Fellowship at Lankenau Hospital, Wynnewood, PA from 2006-2007.  He completed a Colorectal Surgery Residency at NewYork-Presbyterian Hospital/Weill Cornell and Columbia from 2007-2008. He was appointed to the attending staff at Lankenau Hospital in Wynnewood, PA  before joining the staff at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

He is a member of the American Society of Colon & Rectal Surgeons and a Fellow of the American College of Surgeons.  He is widely published in peer-reviewed journals and has presented his research in abstracts, posters and oral presentations at many professional society meetings.



Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicaid
  • Medicare
  • Oscar
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Freedom]
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care [Medicare]
  • United Health Care
  • United Health Care [Community Plan]



Carothers AM, Javid SH, Moran AE,  Hunt DH, Redston M, Bertagnolli MM. Deficient E-cadherin adhestion in C57BL/6J-Min/ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility. Exp Cell Res. 2006 312(4):387-400

Moran AE, Hunt DH, Javid SA, Redston M, Carothers AM, Bertagnolli MM. Apc deficiency is associated with increased EGFR activity in the intestinal enterocytes and adenomas of c57bl/6j-min/ mice. Journal of Biological Chemistry.  2004;279(41), 43261-43272.

Hughes, SA, Carothers AM, Hunt DH, Moran AE, Mueller JD, Bertagnolli MM. Adenomatous polyposis coli truncation alters cytoskeletal structure and microtubule stability in early tumorigenesis. Journal of Gastrointestinal Surgery. 2002; 6(6):868-875

Colinas RJ, Hunt DH, Walsh AC, Lawrence DA. Hydroquinone resistance in a murin myeloblastic leukemia cell line. Involvement of quinone reductase and glutathione-dependent detoxification in nonclassical multidrug resistance. Biochemical Pharmacology. 1996;52 (6): 945-56

Coffee, C, Hunt, DH, et. al  USMLE STEP 1, Biochemistry, Molecular Biology, Cell Biology. 1997 ed. Kaplan Medical, 1997

Honors and Awards

Resident Poster Presentation, New York Society of Colon and Rectal Surgery, 2008

Resident Teaching Award, SUNY Downstate 2006